Innovus Pharmaceuticals, Inc. (OTCQB:INNV), Exclusive Interview for Interlinked's Investment News Channel

Share Article

Innovus Pharmaceuticals, Inc. (OTCQB:INNV) an emerging pharmaceuticals company that delivers safe, innovative and effective non-prescription over-the counter medicine and consumer care products to improve men and women’s health and vitality, granted Interlinked an exclusive interview at the recent FSXinterlinked Investment Conference held at Westlake Village, California

News Image

Innovus Pharma was one of the presenting companies at the recent FSXinterlinked Investment Conference, held at the Four Seasons Hotel in Westlake Village, California.

During the event, FSXinterlinked host, Michael Fugler, interviewed Dr. Bassam Damaj, President and CEO of Innovus Pharmaceuticals.

"Michael asks just the right questions to get the simplest, most informative descriptions of what our presenting companies do and who these entrepreneurs are,” stated Mr. Delray Wannemacher, interlinked President & CEO.

During the interview, Dr. Damaj gave an overview of the Company and said "The Company has been public since 2011. We are trading on the bulletin board OTC:QB under the symbol INNV. The company is a commercial stage pharma company. We currently commercialize 4 products in the US and Canada and they are available through retail and online stores. We focus on the male and female sexual dysfunction and vitality products with Zestra® being our lead product.”

Innovus Pharma is currently focused on developing and acquiring/in-licensing revenue generating OTC and consumer care products in our areas of expertise. With multiple near term upcoming milestones including the expected announcement of two commercial partnerships, acquisition of revenue generating products and in-licensing a proprietary and validated topical drug delivery technology platform, the Company is poised for fast near term growth.

The complete exclusive interview is available only on interlinked.com

More information on Innovus Pharma can be found on http://www.innovuspharma.com; http://www.zestra.com , http://www.ejectdelay.com and on Innovus's Public Profile on Interlinked.com

About FSXinterlinked Investment Conference
FSXinterlinked is the premier investment conference organization in the United States. Founded as Financial Services Exchange (FSX) in 1983, it is one of the longest standing and most trusted investment conferences in the country for Broker Dealers and financial professionals. For more information about our organization please visit FSXinterlinked.com

About Interlinked
Interlinked is a global investment community of investors, emerging growth companies, and resource partners. Interlinked offers an efficient way for companies to maximize exposure and access a private network of funding sources and verified service providers. For investors, Interlinked provides a secure environment to find, vet and engage companies, and communicate with members. Interlinked gives members exclusive access to a proprietary investment platform, which integrates virtual data rooms, video news, a service provider marketplace, an event directory, and customized marketing services, including email marketing, video production, public relations and more. For more information, visit: http://www.interlinked.com/.

Safe Harbor Statement
This press release may contain information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release, including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Delray Wannemacher
@Interlinked
since: 07/2012
Follow >
Interlinked
Like >
Interlinked

Visit website